FDA 483 - TG Labs, Inc. - September 29, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
TG Labs, Inc. in Centennial, CO, a manufacturer of Tetracycline 3% Ointment, was cited for significant deficiencies in its quality control unit, laboratory practices, and facility controls during an FDA inspection. The observations highlight issues with written procedures, record-keeping, equipment calibration, and prevention of contamination and mix-ups. Several observations were removed after discussion, indicating some resolution or clarification during the inspection.
ID · 32d59109-bb29-4edc-b6fa-558a5da691d8